United Therapeutics in downtown Silver Spring has ... our relentless mission to expand the availability of transplantable organs,” said Leigh Peterson, UT’s Executive Vice President of Product ...

After years of research into xenotransplantation, the field is at a turning point—yet risks and ethical issues remain ...

Some scientists are confident that organs from genetically modified pigs will one day be routinely transplanted into humans.

It's early days for xenotransplantation, but eGenesis, Eledon, United Therapeutics and more are working to develop solutions ...

United Therapeutics Corporation ... which are development-stage organ products. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable ...

This segment can turn into a multibillion-dollar market, which will allow United Therapeutics to become a world leader in the field of bio-artificial organs. The company also continues to expand ...

Data from ralinepag studies are expected next year United Therapeutics has different kinds of organ manufacturing products in clinical and preclinical development. These include ...

Building a climate-controlled warehouse and logistics facility for United Therapeutics in North Carolina’s Research Triangle was a matter of power management and careful planning. The facility ...

BofA lowered the firm’s price target on United Therapeutics (UTHR) to $314 from $328 and keeps an Underperform rating on the shares. The firm ...

At United Therapeutics, our vision and mission are ... technologies that expand the availability of transplantable organs. You can learn more about what it means to be a PBC here: unither.com ...

The transplant is the fourth xenotransplant using United Therapeutics’ xeno organs into living humans, following two successful UHeart transplants at the University of Maryland Medicine in 2022 ...